Log In
Sign Up
Cytosine arabinoside, cytarabine
Indications
Acute myeloid leukemia (AML) which include - acute promyelocytic, monocytic, myelomonocytic, megakaryoblastic, and erythroid leukemias; acute lymphocytic leukemia (ALL); meningeal leukemia and other meningeal neoplasms; chronic myelogenous leukemia (CML); non-Hodgkin's lymphomas in children; myelodysplastic syndrome. It is used principally as a component of various chemotherapeutic regimens.
Dose/Application
100 mg/m2/day by continuous IV infusion from day 1 through 7 or 100 mg/ m2IV every 12 hours day 1 through 7 [in combination with other antineoplastics]. Consult specialist literature for further information.
Mode of action
Precautions
Contraindications
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Biobin Injection 100mg 1 KES578.00
Cytosar. inj 100mg/5mL 1 KES715.00
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us